ACAD  220715C00028000

Bought 100% more ACAD $28 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Abilash Satya

Bought ACAD $28 Calls

ACAD  180629C00022000

Traded ACAD $22 Calls

Chris J

acadia pharmaceuticals (nasdaq: acad) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in related central nervous system (cns) disorders. all of acadia's product candid

Acadia Pharmaceuticals Inc.

Sold 88% of ACAD

Six Montahue

Sold 47% of ACAD

Bought 50% more ACAD

Sold all ACAD

New position in ACAD

Sold 50% of ACAD

Bought 100% more ACAD

Pink Pong

Sold 60% of ACAD

Sold 29% of ACAD

Bought 17% more ACAD

Bought 20% more ACAD

Bought 11% more ACAD

Bought 12% more ACAD

Bought 33% more ACAD

Sold 25% of ACAD